School of Medicine

Dayna S. Early, MD, a professor at the School of Medicine, will receive the 2023 Distinguished Endoscopic Research Mentoring Award from the American Society for Gastrointestinal Endoscopy.

The pre-nursing program at University College gives School of Medicine employees and other working adults the academic foundation to enter a bachelor’s of nursing program. The program is flexible, feasible and for most university employees, free. 

Patrick White, MD, PhD, director of the Division of Palliative Medicine in the Department of Medicine at the School of Medicine, has been selected to receive the 2023 Josefina B. Magno Distinguished Hospice Physician Award from the American Academy of Hospice and Palliative Medicine.

A new drug has been approved by the Food and Drug Administration (FDA) for a rare, inherited form of amyotrophic lateral sclerosis (ALS). The drug — based in part on research conducted at the School of Medicine — slows the progression of the deadly, paralyzing disease.

A new study led by the School of Medicine suggests that circadian rhythm — the natural cycle of physical and other changes our bodies go through in a 24-hour period — may affect the body’s response to the COVID-19 vaccine. The research suggests that vaccines given around the middle of the day may prevent more infections.

Washington University is partnering with the National Academies of Sciences, Engineering, and Medicine in its efforts to stimulate cultural change and support inclusive excellence in science and technology fields and is hosting a day of activities May 3 on the Danforth Campus.

Tsuyoshi Kaneko, MD, chief of the cardiac surgery section in the Department of Surgery at the School of Medicine, has been named the John M. Shoenberg Chair in Cardiovascular Disease.

Four faculty members of Washington University in St. Louis were elected members of the American Academy of Arts & Sciences, the academy announced April 19. They are Jean Allman, Scott J. Hultgren, Tristram R. Kidder and Lilianna Solnica-Krezel.

An FDA-approved sleeping pill reduced levels of Alzheimer’s proteins in a small study of healthy volunteers led by School of Medicine researchers. The study hints at the potential of sleep medications to slow or stop Alzheimer’s progression, although much more research is needed regarding such an approach.

A new study by researchers at the School of Medicine reveals that a connection between the body and mind is built into the structure of the brain.